• 719-347-5400
  • info@realmofcaring.org
  • 719-347-5400
  • info@realmofcaring.org
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
Menu
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
  • Donate
  • Register
  • Login
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
Menu
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
  • Donate
  • Login

Research Library

A-Z Conditions  Participate in ORR

Cannabinoids and Epilepsy

  • Journal : Neurotherapeutics
  • Publication Year : 2015
  • Authors : Evan C. Rosenberg, Richard W. Tsien, Benjamin J. Whalley, & Orrin Devinsky

Abstract

 

Cannabis has been used for centuries to treat seizures. Recent anecdotal reports, accumulating animal model data, and mechanistic insights have raised interest in cannabis based anti-epileptic therapies. In this study, we review current understanding of the endocannabinoid system, characterize the pro- and anti-convulsive effects of cannabinoids [e.g., Δ9-tetrahydrocannabinol and cannabidiol (CBD)], and highlight scientific evidence from pre-clinical and clinical trials of cannabinoids in epilepsy. These studies suggest that CBD avoids the psychoactive effects of the endocannabinoid system to provide a well-tolerated, promising therapeutic for the treatment of seizures, while whole-plant cannabis can both contribute to and reduce seizures. Finally, we discuss results from a new multicenter, open-label study using CBD in a population with treatment-resistant epilepsy. In all, we seek to evaluate our current understanding of cannabinoids in epilepsy and guide future basic science and clinical studies.

Read the Full Article

Share This:

Share on Twitter Share on Facebook Share on LinkedIn Share on Email
PrevPreviousBiphasic effects of THC in memory and cognition
NextDose-dependent Effects of Smoked Cannabis on Capsaicin induced Pain and Hyperalgesia in Healthy VolunteersNext

Conditions:

Research Information:

Research Keywords:

Search the Research Library >

Follow Us:

Facebook Twitter Youtube

REGISTER WITH THE RoC TODAY!

Realm of Caring focuses on research, education, building community, and improving quality of life. We are an educational resource for consumers, physicians, scientists, governments and the media.
Register now
  • 5040 Corporate Plaza Drive, Suite 7R, Colorado Springs, CO 80919
  • 719-347-5400
  • info@realmofcaring.org

Copyright © 2021 / Realm of Caring Foundation, Inc

  • Privacy
  • Disclaimer